Negative functional effects of cGMP mediated by cGMP protein kinase are reduced in T4 cardiac myocytes

European Journal of Pharmacology

Volumn 421, Issue 1, 2001, Pages 23-30

  Engel, Samuel ^a   Yan, Lin ^a   Weiss, Harvey ^a   Scholz, Peter ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

(Rabbit); Hypertrophy; Myocyte; Nitric oxide (NO); Second messenger

Indexed keywords

8 BROMO CYCLIC GMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; KT 5823; THYROXINE;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GEL ELECTROPHORESIS; HEART MUSCLE CELL; MUSCLE FIBER CONTRACTION; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RABBIT;

ALKALOIDS; ANIMALS; CARBAZOLES; CARDIOMEGALY; CELL SIZE; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEART VENTRICLES; INDOLES; PHOSPHORYLATION; RABBITS; THYROXINE;

EID: 0035368721     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)00993-1     Document Type: Article

References (40)

1. Nitric oxide attenuates cardiac cyte contraction
2. Thyroxine-induced left ventricular hypertrophy in the rat
3. Direct anabolic effects of thyroid hormone on isolated mouse heart
4. Species differences in myocardial β-adrenergic receptor regulation in response to hyperthyroidism
5. Biochemical basis of thyroid hormone action in the heart
6. Decreased cardiac concentration of cGMP kinase in hypertensive animals: An index for cardiac vascularization?
7. Role of beta-adrenoceptors in the hypertrophic response to thyroxine
8. Progress in understanding the mechanism and function of cyclic GMP-dependent protein kinase
9. Differences in regional capillary distribution and myocytes size in normal and hypertrophic rat hearts
10. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan
11. Regulation of cardiac ion channels by catecholamines, acetylcholine and second messenger systems
12. Ergometric exercise testing and sensitivity of cyclic guanosine 3′,5′-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction
13. Thyroxine-induced cardiac hypertrophy: Time course of development and inhibition by propranolol
14. Thyroid hormone and the cardiovascular system
15. Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart
16. The amino terminus regulates binding to and activation of cGMP-dependent protein kinase
17. Increased fat and skeletal muscle β-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis
18. Regulation of cardiac cGMP-dependent protein kinase
19. Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase
20. Signal transduction by cGMP in heart
21. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes
22. Urinary cyclic guanosine monophosphate as an indicator of experimental congestive heart failure in rats
23. The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication
24. Advances in our understanding of thyroid hormone action at the cellular level
25. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion
26. 2+ in intact cardiac myocytes
27. Faster protein and ribosome synthesis in thyroxine-induced hypertrophy of rat heart
28. Cyclic GMP regulation of calcium slow channels in cardiac muscle and vascular smooth muscle cells
29. Cyclic GMP protein kinase mediates negative metabolic and functional effects of cyclic GMP in control and hypertrophic rabbit cardiac myocytes
30. Intracellular signaling through protein kinases in the heart
31. 2+ current in rat ventricular myocytes
32. 2+ channel activity by human natriuretic peptide in rabbit heart cells
33. Throxine-induced changes in characteristics and activities of β-adrenergic receptors and adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate systems in the heart may be related to reputed catecholamine supersensitivity in hyperthyroidism
34. Effect of cGMP inhitors on the actions of nitrodilators in rat aorta
35. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes
36. Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase
37. Myocardial metabolic and functional responses to acetylcholine are altered in thyroxine-induced cardiac hypertrophy
38. 2 supply and consumption of rabbit hearts
39. 2 consumption is altered in T4-induced hypertrophy
40. 2 consumption caused by cyclic GMP in cardiac myocytes and L-type calcium channels